CX Institutional’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952K | Buy |
8,860
+165
| +2% | +$17.7K | 0.03% | 271 |
|
|
2025
Q1 | $877K | Sell |
8,695
-1,550
| -15% | -$156K | 0.03% | 285 |
|
|
2024
Q4 | $915K | Buy |
10,245
+1,451
| +16% | +$130K | 0.04% | 271 |
|
|
2024
Q3 | $737K | Buy |
8,794
+73
| +0.8% | +$6.12K | 0.03% | 322 |
|
|
2024
Q2 | $672K | Sell |
8,721
-46
| -0.5% | -$3.54K | 0.03% | 332 |
|
|
2024
Q1 | $600K | Sell |
8,767
-191
| -2% | -$13.1K | 0.03% | 342 |
|
|
2023
Q4 | $518K | Sell |
8,958
-191
| -2% | -$11K | 0.03% | 323 |
|
|
2023
Q3 | $483K | Sell |
9,149
-102
| -1% | -$5.39K | 0.03% | 331 |
|
|
2023
Q2 | $500K | Sell |
9,251
-111
| -1% | -$6K | 0.03% | 348 |
|
|
2023
Q1 | $466K | Buy |
9,362
+1,287
| +16% | +$64.1K | 0.02% | 354 |
|
|
2022
Q4 | $374K | Buy |
+8,075
| New | +$374K | 0.02% | 404 |
|
|
2022
Q3 | – | Sell |
-2,771
| Closed | -$103K | – | 542 |
|
|
2022
Q2 | $103K | Buy |
+2,771
| New | +$103K | 0.01% | 549 |
|
|
2021
Q4 | – | Sell |
-3,305
| Closed | -$143K | – | 401 |
|
|
2021
Q3 | $143K | Buy |
3,305
+275
| +9% | +$11.9K | 0.01% | 394 |
|
|
2021
Q2 | $130K | Buy |
3,030
+719
| +31% | +$30.8K | 0.01% | 394 |
|
|
2021
Q1 | $89K | Buy |
2,311
+413
| +22% | +$15.9K | 0.01% | 396 |
|
|
2020
Q4 | $68K | Buy |
1,898
+1,065
| +128% | +$38.2K | 0.01% | 400 |
|
|
2020
Q3 | $32K | Buy |
833
+382
| +85% | +$14.7K | ﹤0.01% | 456 |
|
|
2020
Q2 | $16K | Buy |
451
+66
| +17% | +$2.34K | ﹤0.01% | 483 |
|
|
2020
Q1 | $13K | Sell |
385
-134
| -26% | -$4.53K | ﹤0.01% | 422 |
|
|
2019
Q4 | $23K | Hold |
519
| – | – | ﹤0.01% | 337 |
|
|
2019
Q3 | $21K | Buy |
+519
| New | +$21K | ﹤0.01% | 364 |
|
|
2019
Q2 | – | Sell |
-210
| Closed | -$8K | – | 951 |
|
|
2019
Q1 | $8K | Buy |
+210
| New | +$8K | ﹤0.01% | 477 |
|